{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Erythroid differentiation", "FLI1", "Lactic acid", "Leukemia progression", "PKLR", "Pyruvate"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36586017", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "05"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "31"}], "Language": ["eng"], "ELocationID": ["10.1007/s12032-022-01867-w"], "Journal": {"ISSN": "1559-131X", "JournalIssue": {"Volume": "40", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "31"}}, "Title": "Medical oncology (Northwood, London, England)", "ISOAbbreviation": "Med Oncol"}, "ArticleTitle": "FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes.", "Pagination": {"StartPage": "69", "MedlinePgn": "69"}, "Abstract": {"AbstractText": ["In cancer cells, multiple oncogenes and tumor suppressors control glycolysis to sustain rapid proliferation. The ETS-related transcription factor Fli1 plays a critical role in the induction and progression of leukemia, yet, the underlying mechanism of this oncogenic event is still not fully understood. In this study, RNAseq analysis of FLI1-depleted human leukemic cells revealed transcriptional suppression of the PKLR gene and activation of multiple glycolytic genes, such as PKM1/2. Pharmacological inhibition of glycolysis by PKM2 inhibitor, Shikonin, significantly suppressed leukemic cell proliferation. FLI1 directly binds to the PKLR promoter, leading to the suppression of this inhibitor of glycolysis. In accordance, shRNA-mediated depletion of PKLR in leukemic HEL cells expressing high levels of FLI1 accelerated leukemia proliferation, pointing for the first time to its tumor suppressor function. PKLR knockdown also led to downregulation of the erythroid markers EPOR, HBA1, and HBA2 and suppression of erythroid differentiation. Interestingly, silencing of PKLR in HEL cells significantly increased FLI1 expression, which was associated with faster proliferation in culture. In FLI1-expressing leukemic cells, lower PKLR expression was associated with higher expression of PKM1 and PKM2, which promote aerobic glycolysis. Finally, injection of pyruvate, a known inhibitor of glycolysis, into leukemia mice significantly suppressed leukemogenesis. These results demonstrate that FLI1 promotes leukemia in part by inducing glycolysis, implicates PKLR in erythroid differentiation, and suggests that targeting glycolysis may be an attractive therapeutic strategy for cancers driven by FLI1 overexpression."], "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Sheng", "ForeName": "Danmei", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Chen", "ForeName": "Beiling", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Xiao", "ForeName": "Xiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Kuang", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Life Science, eBond Pharmaceutical Technology Ltd., Chengdu, People's Republic of China."}], "LastName": "Sample", "ForeName": "Klarke M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, ON, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute - University Health Network, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": ["0000-0001-5764-581X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China. babu@gzcnp.cn."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China. babu@gzcnp.cn."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, Guizhou Province, People's Republic of China. babu@gzcnp.cn."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China. yaacovbendavid@hotmail.com."}], "LastName": "Pan", "ForeName": "Weidong", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou Province, People's Republic of China. wdpan@163.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China. wdpan@163.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "GrantList": [{"GrantID": "U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "21867009", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "82260040", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKHPTRC [2019]5627", "Agency": "Science and Technology Program of Guizhou Province", "Country": ""}, {"GrantID": "QKHJC-ZK[2022]YB297", "Agency": "Science and Technology Program of Guizhou Province", "Country": ""}, {"GrantID": "RN21025", "Agency": "Guizhou Medical University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Oncol", "NlmUniqueID": "9435512", "ISSNLinking": "1357-0560"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.1.40", "NameOfSubstance": "Pyruvate Kinase"}, {"RegistryNumber": "0", "NameOfSubstance": "FLI1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Protein c-fli-1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Carcinogenesis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Glycolysis"}, {"QualifierName": ["genetics", "pathology"], "DescriptorName": "Leukemia"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Pyruvate Kinase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Protein c-fli-1"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zheng J. Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol Lett. 2012;4(6):1151\u20137. https://doi.org/10.3892/ol.2012.928 .", "ArticleIdList": ["10.3892/ol.2012.928"]}, {"Citation": "Li XB, Gu JD, Zhou QH. Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy. Thorac Cancer. 2015;6(1):17\u201324. https://doi.org/10.1111/1759-7714.12148 .", "ArticleIdList": ["10.1111/1759-7714.12148"]}, {"Citation": "Dayton TL, Jacks T, Vander Heiden MG. PKM2, cancer metabolism, and the road ahead. EMBO Rep. 2016;17(12):1721\u201330. https://doi.org/10.15252/embr.201643300 .", "ArticleIdList": ["10.15252/embr.201643300"]}, {"Citation": "Noguchi T, Yamada K, Inoue H, Matsuda T, Tanaka T. The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J Biol Chem. 1987;262(29):14366\u201371.", "ArticleIdList": ["10.1016/S0021-9258(18)47947-1"]}, {"Citation": "Chen M, Zhang J, Manley JL. Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. 2010;70(22):8977\u201380. https://doi.org/10.1158/0008-5472.CAN-10-2513 .", "ArticleIdList": ["10.1158/0008-5472.CAN-10-2513"]}, {"Citation": "David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463(7279):364\u20138. https://doi.org/10.1038/nature08697 .", "ArticleIdList": ["10.1038/nature08697"]}, {"Citation": "Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 2005;15(4):300\u20138. https://doi.org/10.1016/j.semcancer.2005.04.009 .", "ArticleIdList": ["10.1016/j.semcancer.2005.04.009"]}, {"Citation": "Christofk HR, Vander Heiden MG, Harris MH, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452(7184):230\u20133. https://doi.org/10.1038/nature06734 .", "ArticleIdList": ["10.1038/nature06734"]}, {"Citation": "Israelsen WJ, Dayton TL, Davidson SM, et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell. 2013;155(2):397\u2013409. https://doi.org/10.1016/j.cell.2013.09.025 .", "ArticleIdList": ["10.1016/j.cell.2013.09.025"]}, {"Citation": "Bianchi P, Fermo E. Molecular heterogeneity of pyruvate kinase deficiency. Haematologica. 2020;105(9):2218\u201328. https://doi.org/10.3324/haematol.2019.241141 .", "ArticleIdList": ["10.3324/haematol.2019.241141"]}, {"Citation": "Diez A, Gilsanz F, Martinez J, P\u00e9rez-Benavente S, Meza NW, Bautista JM. Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression. Blood. 2005;106(5):1851\u20136. https://doi.org/10.1182/blood-2005-02-0555 .", "ArticleIdList": ["10.1182/blood-2005-02-0555"]}, {"Citation": "Zanella A, Bianchi P. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillieres Best Pract Res Clin Haematol. 2000;13(1):57\u201381. https://doi.org/10.1053/beha.1999.0057 .", "ArticleIdList": ["10.1053/beha.1999.0057"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by friend murine leukemia virus. Proc Natl Acad Sci USA. 1990;87(4):1332\u20136. https://doi.org/10.1073/pnas.87.4.1332 .", "ArticleIdList": ["10.1073/pnas.87.4.1332"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5(6):908\u201318. https://doi.org/10.1101/gad.5.6.908 .", "ArticleIdList": ["10.1101/gad.5.6.908"]}, {"Citation": "Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359(6391):162\u20135. https://doi.org/10.1038/359162a0 .", "ArticleIdList": ["10.1038/359162a0"]}, {"Citation": "Ben-David Y, Gajendran B, Sample KM, Zacksenhaus E. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cell Mol Life Sci. 2022;79(3):163. https://doi.org/10.1038/onc.2014.162 .", "ArticleIdList": ["10.1038/onc.2014.162"]}, {"Citation": "Badwe CR, Lis R, Duran JGB, Kunar B, Rafii S. Fli1 is essential for the maintenance of hematopoietic stem cell homeostasis and function. Blood. 2017;130:3769. https://doi.org/10.1182/blood.V130.Suppl_1.3769.3769 .", "ArticleIdList": ["10.1182/blood.V130.Suppl_1.3769.3769"]}, {"Citation": "Stockley J, Morgan NV, Bem D, et al. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood. 2013;122(25):4090\u20133. https://doi.org/10.1182/blood-2013-06-506873 .", "ArticleIdList": ["10.1182/blood-2013-06-506873"]}, {"Citation": "Wang C, Sample KM, Gajendran B, et al. FLI1 Induces Megakaryopoiesis gene expression through WAS/WIP-dependent and independent mechanisms. Implic Wiskott-Aldrich Syndr Front Immunol. 2021;12:607836. https://doi.org/10.3389/fimmu.2021.607836 .", "ArticleIdList": ["10.3389/fimmu.2021.607836"]}, {"Citation": "Cui JW, Vecchiarelli-Federico LM, Li YJ, Wang GJ, Ben-David Y. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia. 2009;23(7):1311\u20139. https://doi.org/10.1038/leu.2009.20 .", "ArticleIdList": ["10.1038/leu.2009.20"]}, {"Citation": "Liu T, Xia L, Yao Y, et al. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis. 2019;10(2):117. https://doi.org/10.1038/s41419-019-1363-1 .", "ArticleIdList": ["10.1038/s41419-019-1363-1"]}, {"Citation": "Wang C, Song J, Liu W, et al. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression. Int J Oncol. 2020;56(2):430\u20138. https://doi.org/10.3892/ijo.2019.4943 .", "ArticleIdList": ["10.3892/ijo.2019.4943"]}, {"Citation": "Yadav S, Sharma A, Nayik GA, et al. Review of shikonin and derivatives: isolation, chemistry, biosynthesis. Pharmacol Toxicol Front pharmacol. 2022;13:905755. https://doi.org/10.3389/fphar.2022.905755 .", "ArticleIdList": ["10.3389/fphar.2022.905755"]}, {"Citation": "Chen J, Xie J, Jiang Z, Wang B, Wang Y, Hu X. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2. Oncogene. 2011;30(42):4297\u2013306. https://doi.org/10.1038/onc.2011.137 .", "ArticleIdList": ["10.1038/onc.2011.137"]}, {"Citation": "Zhang L, Lemarchandel V, Romeo PH, et al. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing\u2019s sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene. 1993;8(6):1621\u201330."}, {"Citation": "Williamson JR, Jones EA. Inhibition of glycolysis by pyruvate in relation to the accumulation of citric acid cycle intermediates in the perfused rat heart. Nature. 1964;203:1171\u20133. https://doi.org/10.1038/2031171a0 .", "ArticleIdList": ["10.1038/2031171a0"]}, {"Citation": "Dang CV. Links between metabolism and cancer. Genes Dev. 2012;26(9):877\u201390. https://doi.org/10.1101/gad.189365.112 .", "ArticleIdList": ["10.1101/gad.189365.112"]}, {"Citation": "Iurlaro R, Le\u00f3n-Annicchiarico CL, Mu\u00f1oz-Pinedo C. Regulation of cancer metabolism by oncogenes and tumor suppressors. Methods Enzymol. 2014;542:59\u201380. https://doi.org/10.1016/B978-0-12-416618-9.00003-0 .", "ArticleIdList": ["10.1016/B978-0-12-416618-9.00003-0"]}, {"Citation": "Tanner JM, Bensard C, Wei P, et al. EWS/FLI is a master regulator of metabolic reprogramming in Ewing Sarcoma. Mol Cancer Res. 2017;15(11):1517\u201330. https://doi.org/10.1158/1541-7786.MCR-17-0182 .", "ArticleIdList": ["10.1158/1541-7786.MCR-17-0182"]}, {"Citation": "Tijssen MR, Cvejic A, Joshi A, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011;20(5):597\u2013609. https://doi.org/10.1016/j.devcel.2011.04.008 .", "ArticleIdList": ["10.1016/j.devcel.2011.04.008"]}, {"Citation": "Athanasiou M, Clausen PA, Mavrothalassitis GJ, Zhang XK, Watson DK, Blair DG. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ. 1996;7(11):1525\u201334."}, {"Citation": "Klimchenko O, Mori M, Distefano A, et al. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood. 2009;114(8):1506\u201317. https://doi.org/10.1182/blood-2008-09-178863 .", "ArticleIdList": ["10.1182/blood-2008-09-178863"]}, {"Citation": "Liu W, Varier KM, Sample KM, Zacksenhaus E, Gajendran B, Ben-David Y. Erythropoietin signaling in the microenvironment of tumors and healthy tissues. Adv Exp Med Biol. 2020;1223:17\u201330. https://doi.org/10.1007/978-3-030-35582-1_2 .", "ArticleIdList": ["10.1007/978-3-030-35582-1_2"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "16"}, {"Year": "2022", "Month": "10", "Day": "3"}, {"Year": "2022", "Month": "12", "Day": "31", "Hour": "11", "Minute": "14"}, {"Year": "2023", "Month": "1", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "4", "Hour": "6", "Minute": "0"}], "PublicationStatus": "epublish", "ArticleIdList": ["36586017", "10.1007/s12032-022-01867-w", "10.1007/s12032-022-01867-w"]}}], "PubmedBookArticle": []}